Variant report

Variant	nsv975033
Chromosome Location	chr10:23726218-23738848
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr10:23733285-23733343	HepG2	liver:	n/a	n/a
2	ARID3A	chr10:23727699-23728099	K562	blood:	n/a	n/a
3	ATF1	chr10:23737809-23738055	K562	blood:	n/a	n/a
4	ATF1	chr10:23734491-23734809	K562	blood:	n/a	n/a
5	ATF1	chr10:23727682-23728115	K562	blood:	n/a	n/a
6	ATF2	chr10:23737616-23738178	GM12878	blood:	n/a	n/a
7	ATF3	chr10:23727555-23728054	K562	blood:	n/a	chr10:23727842-23727862 chr10:23727864-23727873 chr10:23727831-23727851 chr10:23727728-23727748 chr10:23727840-23727853 chr10:23727947-23727967 chr10:23727841-23727852 chr10:23727871-23727880
8	ATF3	chr10:23727846-23728076	HepG2	liver:	n/a	chr10:23728049-23728058 chr10:23727864-23727873 chr10:23727947-23727967 chr10:23727871-23727880
9	ATF3	chr10:23727825-23728180	GM12878	blood:	n/a	chr10:23727842-23727862 chr10:23728049-23728058 chr10:23727864-23727873 chr10:23727831-23727851 chr10:23727840-23727853 chr10:23727947-23727967 chr10:23728171-23728180 chr10:23727841-23727852 chr10:23728110-23728119 chr10:23727871-23727880
10	ATF3	chr10:23727791-23728059	H1-hESC	embryonic stem cell:	n/a	chr10:23727842-23727862 chr10:23728049-23728058 chr10:23727864-23727873 chr10:23727831-23727851 chr10:23727840-23727853 chr10:23727947-23727967 chr10:23727841-23727852 chr10:23727871-23727880
11	ATF3	chr10:23727809-23728025	GM12878	blood:	n/a	chr10:23727842-23727862 chr10:23727864-23727873 chr10:23727831-23727851 chr10:23727840-23727853 chr10:23727947-23727967 chr10:23727841-23727852 chr10:23727871-23727880
12	ATF3	chr10:23727561-23727818	HepG2	liver:	n/a	chr10:23727728-23727748
13	BACH1	chr10:23729168-23729332	H1-hESC	embryonic stem cell:	n/a	n/a
14	BACH1	chr10:23727445-23728096	H1-hESC	embryonic stem cell:	n/a	n/a
15	BCLAF1	chr10:23727438-23728265	GM12878	blood:	n/a	chr10:23728075-23728088 chr10:23728076-23728089 chr10:23728171-23728184 chr10:23728078-23728091 chr10:23728081-23728094
16	BHLHE40	chr10:23738836-23739129	K562	blood:	n/a	chr10:23739004-23739013
17	BHLHE40	chr10:23734589-23734639	K562	blood:	n/a	n/a
18	BHLHE40	chr10:23727520-23728272	GM12878	blood:	n/a	chr10:23728075-23728091 chr10:23728078-23728094 chr10:23728103-23728119 chr10:23728076-23728092 chr10:23728100-23728116
19	BHLHE40	chr10:23727507-23728120	HepG2	liver:	n/a	chr10:23728075-23728091 chr10:23728078-23728094 chr10:23728103-23728119 chr10:23728076-23728092 chr10:23728100-23728116
20	BHLHE40	chr10:23738810-23739128	HepG2	liver:	n/a	chr10:23739004-23739013
21	BHLHE40	chr10:23728711-23728778	K562	blood:	n/a	n/a
22	BHLHE40	chr10:23727527-23728260	K562	blood:	n/a	chr10:23728075-23728091 chr10:23728078-23728094 chr10:23728103-23728119 chr10:23728076-23728092 chr10:23728100-23728116
23	BRCA1	chr10:23727584-23727783	Hela-S3	cervix:	n/a	n/a
24	BRCA1	chr10:23727607-23727943	HepG2	liver:	n/a	n/a
25	CBX3	chr10:23727330-23727803	K562	blood:	n/a	n/a
26	CCNT2	chr10:23729049-23729330	K562	blood:	n/a	n/a
27	CCNT2	chr10:23727543-23728842	K562	blood:	n/a	chr10:23727864-23727873 chr10:23728171-23728180 chr10:23728307-23728316
28	CEBPB	chr10:23727577-23728130	Hela-S3	cervix:	n/a	n/a
29	CEBPB	chr10:23737838-23738051	IMR90	lung:	n/a	n/a
30	CEBPB	chr10:23737802-23738066	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr10:23730286-23730345	K562	blood:	n/a	n/a
32	CEBPB	chr10:23738390-23738435	K562	blood:	n/a	n/a
33	CEBPB	chr10:23727664-23727698	H1-hESC	embryonic stem cell:	n/a	n/a
34	CHD1	chr10:23728459-23728710	GM12878	blood:	n/a	n/a
35	CHD1	chr10:23737963-23738001	H1-hESC	embryonic stem cell:	n/a	n/a
36	CHD1	chr10:23727586-23727771	GM12878	blood:	n/a	n/a
37	CHD1	chr10:23727661-23727685	H1-hESC	embryonic stem cell:	n/a	n/a
38	CHD1	chr10:23728127-23728274	H1-hESC	embryonic stem cell:	n/a	n/a
39	CHD2	chr10:23727281-23728058	K562	blood:	n/a	chr10:23727865-23727875 chr10:23727891-23727901
40	CHD2	chr10:23727596-23728327	GM12878	blood:	n/a	chr10:23727865-23727875 chr10:23727891-23727901
41	CHD2	chr10:23727531-23728482	Hela-S3	cervix:	n/a	chr10:23727865-23727875 chr10:23727891-23727901
42	CHD2	chr10:23728981-23729224	Hela-S3	cervix:	n/a	n/a
43	CHD2	chr10:23729736-23729747	HepG2	liver:	n/a	n/a
44	CHD2	chr10:23727535-23727995	H1-hESC	embryonic stem cell:	n/a	chr10:23727865-23727875 chr10:23727891-23727901
45	CHD2	chr10:23727621-23728104	HepG2	liver:	n/a	chr10:23727865-23727875 chr10:23727891-23727901
46	CREB1	chr10:23728823-23729123	A549	lung:	n/a	n/a
47	CREB1	chr10:23727713-23728020	ECC-1	luminal epithelium:	n/a	n/a
48	CREB1	chr10:23727547-23728242	K562	blood:	n/a	n/a
49	CREB1	chr10:23737639-23738100	GM12878	blood:	n/a	n/a
50	CREB1	chr10:23727575-23728248	K562	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:23727931-23727981	SK-N-MC	brain:	n/a
2	chr10:23732088-23732138	HepG2	liver:	n/a
3	chr10:23727931-23727981	SK-N-MC	brain:	n/a
4	chr10:23732088-23732138	HepG2	liver:	n/a
5	chr10:23729522-23729572	GM12892	blood:	n/a
6	chr10:23728376-23728426	HEK293	kidney:	embryo
7	chr10:23727984-23728034	CMK	blood:	n/a
8	chr10:23727572-23727622	SAEC	small airway:	n/a
9	chr10:23727984-23728034	ECC-1	luminal epithelium:	n/a
10	chr10:23727572-23727622	NHBE	bronchial:	n/a
11	chr10:23727931-23727981	HCPEpiC	choroid plexus:	n/a
12	chr10:23729247-23729297	AG04449	skin:	fetal
13	chr10:23727931-23727981	IMR90	lung:	fetal
14	chr10:23727931-23727981	CMK	blood:	n/a
15	chr10:23727572-23727622	HEEpiC	esophagus:	n/a
16	chr10:23728250-23728300	HRCEpiC	kidney:	n/a
17	chr10:23727572-23727622	NHDF-neo	bronchial:	n/a
18	chr10:23729247-23729297	SK-N-MC	brain:	n/a
19	chr10:23732088-23732138	HIPEpiC	eye:	n/a
20	chr10:23727984-23728034	GM12891	blood:	n/a
21	chr10:23728250-23728300	BJ	skin:	n/a
22	chr10:23728250-23728300	AG04449	skin:	fetal
23	chr10:23729247-23729297	BJ	skin:	n/a
24	chr10:23729522-23729572	NB4	blood:	n/a
25	chr10:23727984-23728034	Hepatocyte	liver:	n/a
26	chr10:23732088-23732138	PrEC	prostate:	n/a
27	chr10:23728250-23728300	BE2_C	brain:	n/a
28	chr10:23729522-23729572	HCT-116	colon:	n/a
29	chr10:23729247-23729297	HL-60	blood:	n/a
30	chr10:23727984-23728034	HAEpiC	amniotic membrane:	n/a
31	chr10:23727931-23727981	BJ	skin:	n/a
32	chr10:23728250-23728300	ECC-1	luminal epithelium:	n/a
33	chr10:23728250-23728300	RPTEC	kidney:	n/a
34	chr10:23729247-23729297	T-47D	breast:	n/a
35	chr10:23728376-23728426	NB4	blood:	n/a
36	chr10:23728376-23728426	AoSMC	blood vessel:	n/a
37	chr10:23728250-23728300	GM12878	blood:	n/a
38	chr10:23728250-23728300	HUVEC	blood vessel:	n/a
39	chr10:23727984-23728034	PFSK-1	brain:	n/a
40	chr10:23729522-23729572	BJ	skin:	n/a
41	chr10:23732088-23732138	MCF-7	breast:	n/a
42	chr10:23727572-23727622	A549	lung:	n/a
43	chr10:23727984-23728034	NH-A	brain:	n/a
44	chr10:23728250-23728300	Caco-2	colon:	n/a
45	chr10:23727572-23727622	ProgFib	skin:	n/a
46	chr10:23732088-23732138	K562	blood:	n/a
47	chr10:23729247-23729297	NT2-D1	testis:	n/a
48	chr10:23728376-23728426	T-47D	breast:	n/a
49	chr10:23727572-23727622	ovcar-3	ovarian:	n/a
50	chr10:23728250-23728300	GM12891	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr10:23732163..23734973-chr10:23736467..23739152,3	K562	blood:
2	chr10:23734822..23737617-chr10:23738406..23741055,2	MCF-7	breast:
3	chr10:23631888..23635089-chr10:23727661..23730060,4	MCF-7	breast:
4	chr10:23731583..23733567-chr10:23742543..23744623,2	MCF-7	breast:
5	chr10:23718339..23720291-chr10:23725094..23726968,2	K562	blood:
6	chr10:23735979..23737585-chr10:23742563..23744622,2	MCF-7	breast:
7	chr10:23732386..23735333-chr10:23736238..23738738,2	MCF-7	breast:
8	chr10:23718207..23720291-chr10:23725300..23726968,2	K562	blood:
9	chr10:23732769..23734965-chr10:23736236..23739152,2	K562	blood:
10	chr10:23727536..23729786-chr10:23733356..23736222,2	MCF-7	breast:
11	chr10:23726971..23730687-chr10:23732679..23735165,3	MCF-7	breast:
12	chr10:23732163..23734973-chr10:23736467..23739152,3	K562	blood:
13	chr10:23732386..23735333-chr10:23736238..23738738,2	MCF-7	breast:
14	chr10:23737577..23740196-chr10:23740591..23742744,2	K562	blood:
15	chr10:23734822..23737617-chr10:23738406..23741055,2	MCF-7	breast:
16	chr10:23728096..23730469-chr10:23730500..23732412,3	MCF-7	breast:
17	chr10:23732769..23734965-chr10:23736236..23739152,2	K562	blood:
18	chr10:23727770..23728754-chr6:170125045..170126039,2	Hela-S3	cervix:
19	chr10:23726848..23728712-chr10:23736442..23738987,2	K562	blood:
20	chr10:23727668..23728613-chr16:56965645..56966488,2	Hela-S3	cervix:
21	chr10:23729334..23732028-chr10:23747440..23749180,2	MCF-7	breast:

No.	miRNA target gene	miRNA name	Chromosome Location
1	OTUD1	hsa-miR-340-5p	chr10:23730231-23730252
2	OTUD1	hsa-miR-19b-3p	chr10:23730642-23730665
3	OTUD1	hsa-miR-340-5p	chr10:23730709-23730729
4	OTUD1	hsa-miR-19b-3p	chr10:23730155-23730162
5	OTUD1	hsa-miR-181a-5p	chr10:23731061-23731082
6	OTUD1	hsa-miR-320a	chr10:23730200-23730223
7	OTUD1	hsa-miR-19b-3p	chr10:23730142-23730162
8	OTUD1	hsa-miR-181a-5p	chr10:23729959-23729981

Variant related genes	Relation type
OTUD1	TF binding region
OTUD1	CpG island
ENSG00000224215	chromatin interactions
ENSG00000051108	chromatin interactions
ENSG00000179133	chromatin interactions
ENSG00000165312	chromatin interactions
ENSG00000232640	chromatin interactions
ENSG00000227704	chromatin interactions

Extended variants
information (count: 528 )
Associated
traits (count: 38 )

Variant overlapped rSNPs/rCNVs (count:528 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs199585873	chr10:23726221-23726222	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs534826904	chr10:23726228-23726229	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs551442536	chr10:23726233-23726234	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs570675488	chr10:23726264-23726265	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs539247680	chr10:23726312-23726313	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs557989411	chr10:23726317-23726318	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs7084145	chr10:23726374-23726375	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs535719296	chr10:23726400-23726401	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs548563080	chr10:23726417-23726418	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs552713952	chr10:23726419-23726420	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs7080648	chr10:23726421-23726422	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs572053416	chr10:23726426-23726427	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs76238539	chr10:23726446-23726447	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs564164438	chr10:23726485-23726486	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs578151905	chr10:23726489-23726490	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs7097167	chr10:23726492-23726493	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs561130134	chr10:23726498-23726499	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs7097185	chr10:23726526-23726527	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs190008173	chr10:23726582-23726583	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs549975556	chr10:23726654-23726655	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs542899327	chr10:23726675-23726676	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs373945058	chr10:23726691-23726692	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs559352410	chr10:23726710-23726711	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs528466138	chr10:23726756-23726757	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs564928698	chr10:23726768-23726769	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs1995981	chr10:23726776-23726777	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs571660189	chr10:23726802-23726803	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs144505519	chr10:23726815-23726816	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs145428057	chr10:23726836-23726837	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs569797919	chr10:23726850-23726851	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs535781809	chr10:23726856-23726857	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs371683026	chr10:23726876-23726877	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs555677898	chr10:23726896-23726897	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs565726363	chr10:23726899-23726900	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs565360122	chr10:23726914-23726915	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs7084695	chr10:23726933-23726934	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs7101025	chr10:23726962-23726963	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs577665271	chr10:23726964-23726965	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs74122448	chr10:23726974-23726975	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs557309205	chr10:23726983-23726984	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs573875621	chr10:23727034-23727035	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs542964458	chr10:23727049-23727050	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs559612726	chr10:23727055-23727056	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs528719612	chr10:23727059-23727060	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs545004660	chr10:23727074-23727075	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs565256812	chr10:23727092-23727093	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs530925056	chr10:23727099-23727100	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs551036546	chr10:23727142-23727143	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs377051788	chr10:23727152-23727153	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs60098864	chr10:23727153-23727154	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:38)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Glioblastoma multiforme	22286061	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:869 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:23721400-23727400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
2	chr10:23721800-23727200	Weak transcription	HMEC	breast
3	chr10:23721800-23727400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr10:23721800-23727400	Weak transcription	NHEK	skin
5	chr10:23722000-23727200	Weak transcription	Rectal Mucosa Donor 29	rectum
6	chr10:23722000-23727200	Weak transcription	Rectal Mucosa Donor 31	rectum
7	chr10:23722200-23727000	Weak transcription	Hela-S3	cervix
8	chr10:23723200-23727000	Weak transcription	Primary B cells from peripheral blood	blood
9	chr10:23723400-23726800	Weak transcription	Primary B cells from cord blood	blood
10	chr10:23724400-23727000	Enhancers	Monocytes-CD14+_RO01746	blood
11	chr10:23724800-23727200	Enhancers	Primary monocytes fromperipheralblood	blood
12	chr10:23725200-23727200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
13	chr10:23725600-23727400	Enhancers	Stomach Mucosa	stomach
14	chr10:23726200-23726400	Enhancers	Breast Myoepithelial Primary Cells	Breast
15	chr10:23726200-23727200	Enhancers	Primary neutrophils fromperipheralblood	blood
16	chr10:23726400-23727400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
17	chr10:23726600-23727000	Enhancers	Skeletal Muscle Male	skeletal muscle
18	chr10:23726600-23727400	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
19	chr10:23726800-23727200	Enhancers	Primary B cells from cord blood	blood
20	chr10:23726800-23727400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
21	chr10:23726800-23727400	Enhancers	Brain Hippocampus Middle	brain
22	chr10:23726800-23727400	Enhancers	Placenta	Placenta
23	chr10:23727000-23727200	Enhancers	Rectal Smooth Muscle	rectum
24	chr10:23727000-23727200	Enhancers	Hela-S3	cervix
25	chr10:23727000-23727200	Enhancers	K562	blood
26	chr10:23727000-23727400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr10:23727000-23727400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr10:23727000-23727400	Enhancers	Primary B cells from peripheral blood	blood
29	chr10:23727000-23727400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
30	chr10:23727000-23727400	Enhancers	Primary T helper naive cells from peripheral blood	blood
31	chr10:23727000-23727400	Enhancers	Adipose Nuclei	Adipose
32	chr10:23727000-23727400	Enhancers	Brain Substantia Nigra	brain
33	chr10:23727000-23727400	Enhancers	Fetal Intestine Large	intestine
34	chr10:23727000-23727400	Enhancers	Fetal Muscle Trunk	muscle
35	chr10:23727000-23727400	Enhancers	Fetal Muscle Leg	muscle
36	chr10:23727000-23727400	Enhancers	Left Ventricle	heart
37	chr10:23727000-23727400	Enhancers	Right Atrium	heart
38	chr10:23727000-23727600	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
39	chr10:23727000-23727800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
40	chr10:23727000-23728400	Active TSS	ES-WA7 Cell Line	embryonic stem cell
41	chr10:23727200-23727400	Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
42	chr10:23727200-23727400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
43	chr10:23727200-23727400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
44	chr10:23727200-23727400	Enhancers	Primary hematopoietic stem cells short term culture	blood
45	chr10:23727200-23727400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
46	chr10:23727200-23727400	Enhancers	Primary T helper cells PMA-I stimulated	--
47	chr10:23727200-23727400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
48	chr10:23727200-23727400	Enhancers	Primary T helper cells fromperipheralblood	blood
49	chr10:23727200-23727400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
50	chr10:23727200-23727400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links